These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 2050587)

  • 1. Activity of human extravascular temocillin concentrations simulated in an in-vitro kinetic model against beta-lactamase producing gram-negative bacilli.
    Cooper CE; White AR; Slocombe B
    J Antimicrob Chemother; 1991 Jan; 27(1):105-15. PubMed ID: 2050587
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Temocillin. In vitro antibacterial activity.
    Slocombe B; Cooper CE; Griffin KE; White AR
    Drugs; 1985; 29 Suppl 5():49-56. PubMed ID: 3849425
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vitro Temocillin efficacy against extended spectrum β-lactamase producing multidrug resistant gram negative bacterial isolates from Nepal.
    Kandel BP; Bhatta DR; Shakya G; Upadhayay BP; Dumre SP; Poudyal S; Adhikari N; Acharya D
    Nepal Med Coll J; 2014 Dec; 16(2-4):144-7. PubMed ID: 26930733
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Beta-lactamase stability of temocillin.
    Edmondson RA; Reading C
    Drugs; 1985; 29 Suppl 5():64-6. PubMed ID: 3875474
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antibacterial activity and beta-lactamase stability of temocillin.
    Jules K; Neu HC
    Antimicrob Agents Chemother; 1982 Sep; 22(3):453-60. PubMed ID: 6982681
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vitro activity of temocillin, moxalactam and cefotaxime against gram negative bacteria sensitive or resistant to ureidopenicillins and/or cefacedone.
    Bartmann K; Tarbuc R
    Zentralbl Bakteriol Mikrobiol Hyg A; 1983 Dec; 256(2):202-10. PubMed ID: 6324518
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Temocillin. In vitro activity compared with other antibiotics.
    Martinez-Beltran J; Loza E; Gomez-Alferez A; Romero-Vivas J; Bouza E
    Drugs; 1985; 29 Suppl 5():91-7. PubMed ID: 3875477
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Temocillin: in vitro activity against 734 selected clinical isolates, including beta-lactamase-producing strains.
    Fuchs PC; Barry AL; Jones RN; Thornsberry C
    Diagn Microbiol Infect Dis; 1984 Jan; 2(1):55-63. PubMed ID: 6443203
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vitro activity of temocillin against extended spectrum beta-lactamase-producing Escherichia coli.
    Rodriguez-Villalobos H; Malaviolle V; Frankard J; de Mendonça R; Nonhoff C; Struelens MJ
    J Antimicrob Chemother; 2006 Apr; 57(4):771-4. PubMed ID: 16501056
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bactericidal activity of ertapenem against major intra-abdominal pathogens.
    Borbone S; Cascone C; Santagati M; Mezzatesta ML; Stefani S
    Int J Antimicrob Agents; 2006 Nov; 28(5):396-401. PubMed ID: 17045463
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparative in vitro activity of temocillin.
    Gobernado M; Canton E
    Drugs; 1985; 29 Suppl 5():24-31. PubMed ID: 4029029
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The activity of temocillin against Enterobacteriaceae, Pseudomonas and Haemophilus influenzae.
    Chen HY; Williams JD
    Drugs; 1985; 29 Suppl 5():85-90. PubMed ID: 3875475
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bacteriostatic and bactericidal activity of penicillins at constant and variable concentrations.
    Bauernfeind A
    Drugs; 1985; 29 Suppl 5():9-14. PubMed ID: 3875476
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effects on beta-lactam susceptibility of phenotypic induction and genotypic derepression of beta-lactamase synthesis.
    Shannon K; Phillips I
    J Antimicrob Chemother; 1986 Dec; 18 Suppl E():15-22. PubMed ID: 3102451
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Carumonam's in-vitro activity against gram-negative bacteria and its stability to their beta-lactamases.
    Raimondi A; Mattina R; Cocuzza CE
    Chemioterapia; 1988 Feb; 7(1):3-9. PubMed ID: 3288365
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In-vitro activity of tigemonam, an oral monobactam, against gram-negative rods, including variants in beta-lactamase-production.
    Brown J; Yang YJ; Livermore DM
    J Antimicrob Chemother; 1989 Feb; 23(2):201-7. PubMed ID: 2785102
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Temocillin revived.
    Livermore DM; Tulkens PM
    J Antimicrob Chemother; 2009 Feb; 63(2):243-5. PubMed ID: 19095679
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vitro activity against clinically important gram-positive and gram-negative bacteria of sulbactam, alone and in combination with ampicillin, cefotaxime, mezlocillin, and piperacillin.
    Schmalreck AF; Wildfeuer A
    Arzneimittelforschung; 1990 Oct; 40(10):1145-55. PubMed ID: 2291754
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vitro activity of avibactam (NXL104) in combination with β-lactams against Gram-negative bacteria, including OXA-48 β-lactamase-producing Klebsiella pneumoniae.
    Aktaş Z; Kayacan C; Oncul O
    Int J Antimicrob Agents; 2012 Jan; 39(1):86-9. PubMed ID: 22041508
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of the MicroScan ESBL plus confirmation panel for detection of extended-spectrum beta-lactamases in clinical isolates of oxyimino-cephalosporin-resistant Gram-negative bacteria.
    Stürenburg E; Lang M; Horstkotte MA; Laufs R; Mack D
    J Antimicrob Chemother; 2004 Nov; 54(5):870-5. PubMed ID: 15471997
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.